Shares of Apogee Therapeutics have gained 34% over the past two days as the small biotech looks to take on Regeneron and ...

Patient BMI did not affect treatment outcomes across several efficacy measures among patients with AD who were treated with JAK inhibitors.

Sanofi and Galderma are competitors in the pharmaceutical space. Galderma’s Nemluvio is a monoclonal antibody approved by the FDA to treat adults with PN, and to treat moderate-to-severe eczema in ...

Zoryve cream gains FDA approval for treating mild to moderate atopic dermatitis in young children, offering a safe, ...

This approval follows the recent FDA approval of ruxolitinib cream 1.5% (Opzelura), a topical JAK inhibitor, as a treatment ...

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) shares gained 1.5% in premarket trading Monday after the U.S. Food and Drug ...

ZORYVE cream 0.05% provides rapid and effective relief of mild to moderate atopic dermatitis in children ages 2 to 5 and is safe and well ...

Pfizer delivered strong 2Q25 results with double-digit revenue growth and margin expansion. Click here to read why PFE stock ...

Nektar Therapeutics was founded in 1990, but it doesn't have any commercial-stage drugs that generate revenue righ ...

True or False: Early data from a randomized trial showed that acetaminophen (Tylenol) led to a greater risk of eczema in ...

The pharmaceutical giant has granted the president’s long-standing demands. Other drug companies could be next.

She’s touting “skin-friendly tips for the whole family” on behalf of Henkel’s All Free Clear, which has been advertising itself as the “detergent made for sensitive skin” -- such as in this recent ...